Daily Arxiv

This page organizes papers related to artificial intelligence published around the world.
This page is summarized using Google Gemini and is operated on a non-profit basis.
The copyright of the paper belongs to the author and the relevant institution. When sharing, simply cite the source.

MOIS-SAM2: Exemplar-based Segment Anything Model 2 for multilesion interactive segmentation of neurofibromas in whole-body MRI

Created by
  • Haebom

Author

Georgii Kolokolnikov, Marie-Lena Schmalhofer, Sophie Goetz, Lennart Well, Said Farschtschi, Victor-Felix Mautner, Inka Ristow, Rene Werner

Outline

This paper proposes a novel interactive segmentation model, MOIS-SAM2, for efficient segmentation of neurofibromas (NFs) in whole-body magnetic resonance imaging (WB-MRI) images of patients with neurofibromatosis type 1 (NF1). MOIS-SAM2 extends the state-of-the-art transformer-based promptable segmentation Nothing Model 2 (SAM2) with example-based semantic propagation. It is trained and evaluated on a dataset of 119 WB-MRI scans from 84 NF1 patients, divided into four test sets reflecting within-domain and domain-shifting scenarios (variable MRI field strength, low tumor burden, and differences in clinical site and scanner manufacturer). On the within-domain test set, MOIS-SAM2 achieves a scan-by-scan DSC of 0.60 against expert manual annotation, outperforming the baseline 3D nnU-Net (DSC: 0.54) and SAM2 (DSC: 0.35). It maintains excellent performance across various domain-shifting scenarios, particularly in the case of low tumor burden. The F1 scores for lesion detection ranged from 0.62 to 0.78 across the test set. The agreement between the model and the expert was comparable to that between experts. In conclusion, MOIS-SAM2 demonstrates its potential for integration into clinical workflows by enabling efficient and scalable NF segmentation with minimal user input.

Takeaways, Limitations

Takeaways:
We present a novel interactive segmentation model that can efficiently segment multiple neurofibromas in whole-body MRI with minimal user intervention.
It shows robust performance even in various domain movement situations.
It provides improved accuracy and scalability compared to existing methods, increasing clinical applicability.
The agreement between the model and the expert was similar to that between the experts, ensuring clinical reliability.
Limitations:
Since the model was trained and evaluated using a limited-sized dataset, verification of generalization performance on a larger dataset is necessary.
It is possible that the characteristics of the various types of neurofibromas may not be fully captured.
This study only presented the results of an initial inter-reader variability analysis, so more in-depth analysis is needed.
👍